" class="no-js "lang="en-US"> MedTech Innovator Asia Pacific Names 24 Startups to Accelerator
Wednesday, June 19, 2024

MedTech Innovator Asia Pacific Names 24 Startups to Annual Accelerator

MedTech Innovator, the world’s largest accelerator of medical technology companies announced today that 24 medtech companies will participate in the fourth annual Asia Pacific Accelerator program.

MedTech Innovator Asia Pacific offers best-in-class startups opportunities to work with investors, business leaders and allied service professionals in the medtech industry to help drive commercialization of life-changing technologies throughout the region. The 2023 cohort companies will also compete for up to US$ 300,000 in cash prizes and awards.

“As the world’s largest accelerator of medtech companies, MedTech Innovator established the Asia Pacific Program in 2019 because of the incredible innovation in the region. We look forward to working with our partners to support this year’s cohort of companies and to help them advance their technologies,” said Paul Grand, CEO of MedTech Innovator.

Over 400 companies applied for the Asia Pacific program this year, and after a rigorous selection process, 60 companies were invited to pitch, 24 of which were named to the 2023 cohort. In early December, four startups from the 2023 Asia Pacific cohort will advance to compete in the Grand Finals to be held at APACMed’s Medtech Forum 2023 in Singapore. Attended by health care industry leaders, health care providers, and investors from across the region, the MedTech Forum will also showcase solutions from all 24 Accelerator cohort companies. The winning company, which will be determined by audience vote, stands to win a non-dilutive cash prize and the title of the 2023 MedTech Innovator Asia Pacific Winner.

For the first time, MedTech Innovator Asia Pacific’s 2023 cohort will include four shortlisted companies that are part of the inaugural Olympus Asia Pacific Innovation Program (OAIP). This program focuses on minimally invasive care and new ways to detect, monitor, and treat conditions and diseases. The winning innovator will receive grant funding of US$ 75,000 as well as an exclusive mentorship program with key thought leaders from within Olympus.

The 24 companies selected to the 2023 MedTech Innovator Asia Pacific Accelerator are:

  • Accuster Technologies (India)
  • Astron Medtech (US)
  • Biotome (Australia)
  • Flexperc Medical (US)
  • Gbrain (South Korea)
  • GenLight Medical (China)
  • Healium Medical (Israel)
  • Jdot (Changzhou) Medical Technology (China)
  • Kinexcs (Singapore)
  • Lifespans (Hong Kong, China)
  • Medipixel (South Korea)
  • MedySapiens (South Korea)
  • Module Innovations (India)
  • Neurowyzr (Singapore)
  • NICE Surgical Solutions (Singapore)
  • Ossfila Technology (Hong Kong, China)
  • PrimaNova Technologies (Hong Kong, China)
  • Thrixen (Singapore)
  • Vivo Surgical (Singapore)
  • Weinnovate Biosolutions (India)

The companies shortlisted for the OAIP are:

  • BioCliq (India)
  • NDR Medical (Singapore)
  • Sonire Therapeutics (Japan)
  • Vesica Corporation (US)

MedTech Innovator’s 2023 Asia Pacific program sponsors include Johnson & Johnson, Olympus, Teleflex, Siemens Healthineers, B Braun Medical, Cambridge Consultants, JABIL Healthcare and Enterprise Singapore. The MedTech Innovator Asia Pacific Program is held in partnership with APACMed.

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more